Calico (company)
Calico (company)
Jump to navigation
Jump to search
Type | Subsidiary |
---|---|
Industry |
|
Founded | September 18, 2013 (2013-09-18) |
Founders | Bill Maris[1][2][3][4] |
Headquarters | South San Francisco, California , United States |
Area served | Worldwide |
Key people | Arthur D. Levinson (CEO) |
Parent | Google (2013–2015) Alphabet Inc. (2015–present) |
Website | calicolabs.com |
Calico LLC is an American research and development biotech company founded on September 18, 2013 by Bill Maris[3][4][2][1] and backed by Google with the goal of combating aging and associated diseases.[5] In Google's 2013 Founders' Letter, Larry Page described Calico as a company focused on "health, well-being, and longevity". The company's name is an acronym for "California Life Company".[6][7]
In 2015, Google restructured into Alphabet Inc., making Calico a subsidiary of the new company along with Google and others. As of 2018, Calico has not developed any known drugs or biotechnology products.[8]
Contents
1 Partnerships and staff
2 See also
3 References
4 External links
Partnerships and staff[edit]
In September 2014, it was announced that Calico, in partnership with AbbVie, would be opening up an R&D facility focused on aging and age-related diseases, such as neurodegeneration and cancer. Initially, each company will invest $350 million, with an option for each to add an extra $500 million later on.[9] In the same month, Calico announced a partnership with the University of Texas Southwestern Medical Center and 2M Companies regarding drug development for neurodegenerative disorders.[10]
In 2015, the Broad Institute of MIT and Harvard announced a partnership with Calico to "advance research on age-related diseases and therapeutics",[11] a further partnership also was announced with the Buck Institute for Research on Aging.[12] Also in 2015, Calico announced a partnership with QB3 based on researching the biology of aging and identifying potential therapeutics for age-related diseases[13] and one with AncestryDNA based on conducting research into the genetics of human lifespan.[14]
At the end of 2017 and the beginning of 2018, Calico lost two top scientists; in December 2017 Hal Barron, its head of R&D, left for GlaxoSmithKline, and in March 2018 Daphne Koller, who was leading their AI efforts, left to pursue a venture in applying machine learning techniques to drug design.[15][16]
See also[edit]
- Verily
References[edit]
^ ab "The brains behind Calico? Bill Maris of Google Ventures". VentureBeat. Retrieved 16 February 2018..mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"""""""'""'"}.mw-parser-output .citation .cs1-lock-free a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .citation .cs1-lock-subscription a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}
^ ab Regalado, Antonio. "Can naked mole rats teach us the secrets to living longer?". Retrieved 16 February 2018.
^ ab Naughton, John (9 April 2017). "Why Silicon Valley wants to thwart the grim reaper". The Guardian. London. Retrieved 16 February 2018.
^ ab Fortuna, W. Harry. "Seeking eternal life, Silicon Valley is solving for death". Quartz. Retrieved 16 February 2018.
^ "Google announces Calico, a new company focused on health and well-being". 18 September 2013.
^ Pollack, Andrew; Miller, Claire Cain (18 September 2013). "Tech Titans Form Biotechnology Company". The New York Times. Retrieved 18 January 2015.
^ Page, Larry. "2013 Founders' Letter".
^ Womack, Brian (10 August 2015). "Google Creates New Company Called Alphabet, Restructures Stock". Bloomberg. Retrieved 10 August 2015.
^ "AbbVie and Calico Announce a Novel Collaboration to Accelerate the Discovery, Development, and Commercialization of New Therapies". 3 September 2014.
^ "UT Southwestern researchers discover novel class of NAMPT activators for neurodegenerative disease; Calico enters into exclusive collaboration with 2M to develop UTSW technology". 11 September 2014.
^ "Broad Institute and Calico announce an extensive collaboration focused on the biology of aging and therapeutic approaches to diseases of aging".
^ "Google's Calico continues its partnering romp on aging R&D with Buck collaboration".
^ "Calico and QB3 announce partnership to conduct research into the biology of aging and to identify potential therapeutics for age-related diseases". 24 March 2015. Retrieved 6 June 2015.
^ "AncestryDNA and Calico to Research the Genetics of Human Lifespan".
^ Al Idrus, Amirah (March 2, 2018). "Calico loses its second executive in 4 months as Daphne Koller quits". FierceBiotech.
^ https://medium.com/@daphne_38275/insitro-rethinking-drug-discovery-using-machine-learning-dcb0371870ee
External links[edit]
- Official website
Categories:
- GV companies
- Biogerontology
- Health care companies based in California
- Biotechnology companies of the United States
- Life sciences industry
- Life extension organizations
- Biotechnology companies established in 2013
- Alphabet Inc.
- 2013 establishments in California
(window.RLQ=window.RLQ||).push(function(){mw.config.set({"wgPageParseReport":{"limitreport":{"cputime":"0.524","walltime":"0.655","ppvisitednodes":{"value":1790,"limit":1000000},"ppgeneratednodes":{"value":0,"limit":1500000},"postexpandincludesize":{"value":115092,"limit":2097152},"templateargumentsize":{"value":1677,"limit":2097152},"expansiondepth":{"value":17,"limit":40},"expensivefunctioncount":{"value":0,"limit":500},"unstrip-depth":{"value":1,"limit":20},"unstrip-size":{"value":44859,"limit":5000000},"entityaccesscount":{"value":1,"limit":400},"timingprofile":["100.00% 449.246 1 -total"," 38.68% 173.777 1 Template:Reflist"," 27.61% 124.040 1 Template:Infobox_company"," 24.03% 107.948 1 Template:Infobox"," 21.86% 98.221 6 Template:Cite_web"," 13.68% 61.469 7 Template:Navbox"," 10.65% 47.846 9 Template:Cite_news"," 8.76% 39.333 1 Template:Other_uses"," 7.68% 34.486 1 Template:Start_date_and_age"," 7.29% 32.764 1 Template:Alphabet_Inc."]},"scribunto":{"limitreport-timeusage":{"value":"0.203","limit":"10.000"},"limitreport-memusage":{"value":5337345,"limit":52428800}},"cachereport":{"origin":"mw1246","timestamp":"20190121140527","ttl":1900800,"transientcontent":false}}});mw.config.set({"wgBackendResponseTime":85,"wgHostname":"mw1271"});});